Jianerkang (603205.SH), which has been deeply involved in medical dressings for more than 20 years, plans to publicly issue 30 million shares

According to the Zhitong Finance App, Jianerkang (603205.SH) disclosed a prospectus. The number of shares to be publicly issued by the company is 30 million shares, accounting for 25% of the total share capital after issuance. The initial inquiry date for this offering is October 22, 2024, and the subscription date is October 25, 2024. It will be listed on the main board of the Shanghai Stock Exchange as soon as the issuance is completed.

The company's main business is R&D, production and sales of disposable medical devices such as medical dressings and disinfectant hygiene products. According to the purpose of use, the company's products are divided into six series: surgical consumables, wound care, disinfection and cleaning, protective, polymer and auxiliary, and nonwoven fabrics.

The company achieved net profit attributable to the owners of the parent company from 2021 to 2024: RMB 132 million, RMB 157 million, RMB 124 million, and RMB 609.427 million, respectively. In addition, the company expects net profit attributable to owners of the parent company from January to September 2024 to 95.9822 million yuan, an increase of 10.18% to 15.09% over the previous year.

After deducting the corresponding issuance fees, the company's current public offering of shares will all be used for projects related to the company's main business. The specific investment is: high-end medical dressings and nonwovens and products projects, R&D center construction projects, information system upgrading projects, and supplementary working capital. A total of 720 million yuan will be raised.